Pulmatrix Inc (PULM)

May 15, 2025

Pulmatrix set for merger with Cullgen, seeks asset divestment By Investing.com - Investing.com South Africa

May 15, 2025

May 15, 2025

Enliven stops work on solid tumor drug; Pulmatrix to divest assets - Endpoints News

May 15, 2025

May 15, 2025

Pulmatrix Announces Divestment Plan for Assets - citybiz

May 15, 2025

May 15, 2025

Pulmatrix Announces First Quarter 2025 Financial Results and Div - GuruFocus

May 15, 2025

May 15, 2025

Pulmatrix, Inc. SEC 10-Q Report - TradingView

May 15, 2025

May 15, 2025

Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets | PULM Stock News - GuruFocus

May 15, 2025

May 15, 2025

Pulmatrix set for merger with Cullgen, seeks asset divestment - Investing.com

May 15, 2025

May 15, 2025

Pulmatrix to Divest Migraine Drug PUR3100 as Cullgen Merger Approaches: Q1 Earnings Detail Strategic Shift - Stock Titan

May 15, 2025

May 14, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders - The Malaysian Reserve

May 14, 2025

May 09, 2025

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc.PULM - marketscreener.com

May 09, 2025

May 08, 2025

(PULM) Proactive Strategies - news.stocktradersdaily.com

May 08, 2025

May 04, 2025

Geode Capital Management LLC Boosts Holdings in Pulmatrix, Inc. (NASDAQ:PULM) - Defense World

May 04, 2025

May 02, 2025

Pulmatrix, Inc. (NASDAQ:PULM) Holdings Cut by Renaissance Technologies LLC - Defense World

May 02, 2025

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 22, 2025

(PULM) Investment Analysis - news.stocktradersdaily.com

Apr 22, 2025

Apr 09, 2025

Pulmatrix appoints CBIZ as new auditor after Marcum resignation By Investing.com - Investing.com India

Apr 09, 2025

Apr 08, 2025

Pulmatrix appoints CBIZ as new auditor after Marcum resignation - Investing.com

Apr 08, 2025

Apr 06, 2025

Pulmatrix Will Discuss Progress At The Aegis Growth Conference On September 21, 2016 - BioSpace

Apr 06, 2025

Apr 03, 2025

Aspergillosis Market on Track for Major Expansion by 2034, According to DelveInsight | F2G, Pulmatrix, TFF Pharmaceuticals, Scynexis, Pulmocide - The Globe and Mail

Apr 03, 2025

Apr 02, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - ACCESS Newswire

Apr 02, 2025

Mar 28, 2025

Pulmatrix : Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline - MarketScreener

Mar 28, 2025

Mar 27, 2025

Learn to Evaluate (PULM) using the Charts - news.stocktradersdaily.com

Mar 27, 2025

Mar 25, 2025

Pulmatrix Reports 2024 Financials and Merger Plans - TipRanks

Mar 25, 2025

Mar 21, 2025

Pulmatrix Inc. (PULM) reports earnings - Quartz

Mar 21, 2025

Mar 21, 2025

Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - Nasdaq

Mar 21, 2025

Mar 21, 2025

Pulmatrix (NASDAQ:PULM) Stock Price Crosses Above Fifty Day Moving Average – What’s Next? - Defense World

Mar 21, 2025

Mar 21, 2025

Genfit’s up to €185M royalty deal; J&J’s Tremfya gets a Crohn’s approval - Endpoints News

Mar 21, 2025

Mar 16, 2025

(PULM) Trading Report - Stock Traders Daily

Mar 16, 2025

Feb 25, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders - The Malaysian Reserve

Feb 25, 2025

Feb 25, 2025

2025-02-25 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders | NDAQ:CCNE | Press Release - Stockhouse

Feb 25, 2025

Feb 24, 2025

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Pulmatrix, Inc. (PULM) - TradingView

Feb 24, 2025

Feb 19, 2025

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders - Business Wire

Feb 19, 2025

Feb 18, 2025

PULM stock soars to 52-week high, touches $8.5 amid robust gains - Investing.com India

Feb 18, 2025

Feb 18, 2025

PULM stock soars to 52-week high, touches $8.5 amid robust gains By Investing.com - Investing.com South Africa

Feb 18, 2025

Feb 14, 2025

Pulmatrix revises bylaws, changes voting standards - MSN

Feb 14, 2025

Feb 14, 2025

Pulmatrix revises bylaws, changes voting standards By Investing.com - Investing.com Nigeria

Feb 14, 2025

Jan 28, 2025

Pulmatrix's Unique Inhaled Drug Candidate Has "Blockbuster" Potential, Says CFO Bill Duke - ACCESS Newswire

Jan 28, 2025

Jan 22, 2025

Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain - The Manila Times

Jan 22, 2025

Jan 22, 2025

SEC Form 425 filed by Pulmatrix Inc. - Quantisnow

Jan 22, 2025

Jan 22, 2025

Cullgen Begins Phase 1 Dosing of its Potential - GlobeNewswire

Jan 22, 2025

Jan 06, 2025

Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail

Jan 06, 2025

Jan 05, 2025

Pulmatrix (NASDAQ:PULM) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 05, 2025

Dec 28, 2024

Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com - Defense World

Dec 28, 2024

Dec 23, 2024

Pulmatrix, Inc. Holds 2024 Annual Meeting of Stockholders – Final Voting Results Released - Defense World

Dec 23, 2024

Dec 20, 2024

Pulmatrix secures director positions and ratifies accounting firm - Investing.com India

Dec 20, 2024

Dec 20, 2024

Pulmatrix secures director positions and ratifies accounting firm By Investing.com - Investing.com Australia

Dec 20, 2024

Dec 20, 2024

StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM) - Defense World

Dec 20, 2024